Testing Longitudinal Relationships Between Binge Drinking, Marijuana Use, and Depressive Symptoms and Moderation by Sex by Wilkinson, Andra L. et al.
Testing longitudinal relationships between binge drinking, 
marijuana use, and depressive symptoms and moderation by 
sex
Andra L. Wilkinson, M.S.P.H.a,b, Carolyn Tucker Halpern, Ph.D.a,b, Amy H. Herring, Sc.D.a,c, 
Meghan Shanahan, Ph.D.b,d, Susan Ennett, Ph.D.e, Jon Hussey, Ph.D.a,b, and Kathleen 
Mullan Harris, Ph.D.a,f
Andra L. Wilkinson: wilkina@live.unc.edu; Carolyn Tucker Halpern: carolyn_halpern@unc.edu; Amy H. Herring: 
amy_herring@unc.edu; Meghan Shanahan: shanahan@unc.edu; Susan Ennett: sennett@email.unc.edu; Jon Hussey: 
jon_hussey@unc.edu; Kathleen Mullan Harris: kathie_harris@unc.edu
aCarolina Population Center, University of North Carolina at Chapel Hill
bDepartment of Maternal and Child Health, Gillings School of Global Public Health, University of 
North Carolina at Chapel Hill
cDepartment of Biostatistics, Gillings School of Global Public Health, University of North Carolina 
at Chapel Hill
dInjury Prevention Research Center, University of North Carolina at Chapel Hill
eDepartment of Health Behavior, Gillings School of Global Public Health, University of North 
Carolina at Chapel Hill
fDepartment of Sociology, University of North Carolina at Chapel Hill
Abstract
Purpose—Both substance use and depression are common in adolescence and often comorbid. 
Past research has produced conflicting results on whether there is a temporal relationship and if so, 
in which direction it operates and how it may vary by sex. We examined the longitudinal 
associations between substance use frequency and depressive symptoms from adolescence into 
young adulthood, and whether the associations were moderated by sex.
Methods—With data from Waves I, III, and IV of the National Longitudinal Study of Adolescent 
to Adult Health (n=9816), we used growth curve models to test if depressive symptoms predicted 
marijuana use or binge drinking frequency (Self-Medication Model) or if substance use frequency 
predicted depressive symptoms (Stress Model). Moderation by sex and age was tested for both 
potential pathways.
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Results—Increases in adolescent depressive symptoms, compared to no symptoms, were 
associated with a steeper predicted increase in marijuana use frequency from adolescence to young 
adulthood. Increases in persistent binge drinking or marijuana use frequency had concurrent 
positive associations with depressive symptoms from adolescence to young adulthood, and these 
associations were significantly stronger for females compared to males.
Conclusions—The results support the Self-Medication Model for marijuana use but also 
provide modest support for the Stress Model, that substance use is associated with depressive 
symptoms, especially for females.
Keywords
Depression; substance use; adolescent development; gender
Both substance use and depressive symptoms increase in adolescence (12–19 year olds), are 
often comorbid, and are associated with negative outcomes.1–6 Nearly one third of U.S. high 
school students report current alcohol use, approximately one quarter report current 
marijuana use; together these are the two most commonly used substances in adolescence 
and thus the focus of these analyses.7 Up to one in five adolescents have experienced a major 
depressive episode.3 Youth with a major depressive episode in the past year are more than 
twice as likely to report marijuana use compared to youth without a major depressive 
episode in the past year.8 Comorbidity between substance use and depression is concerning 
because it is associated with worse outcomes than either alone, including increases in 
substance use, longer depressive episodes, more severe mental health issues, delays in 
substance abuse recovery, and elevated suicide risk.9
The comorbidity between substance use and depression indicates there may be a causal 
relationship between them. Understanding in which direction the process operates could 
inform how to target and integrate substance use and depression screening, newly covered 
preventive services under the Affordable Care Act.10 Theories suggest alternative directions 
for this relationship. First, the Self-Medication Model asserts depression leads to substance 
use as an attempt to ameliorate symptoms.11 Second, our Stress Model hypothesizes 
substance use leads to depression by increasing strain in peer and parental relationships or 
social isolation and thereby interpersonal stress.12,13 Processes entailed in these Models are 
complicated by biological sex and developmental change. In general, adolescent females are 
more likely to report experiencing depression than males.14,15 By comparison, adolescent 
males generally report use of a wider range of substances and at a higher frequency 
compared to females.5,7,16 Developmentally, initiation of substance use is concentrated in 
adolescence yet the quantity and frequency of substance use typically peak between 18–25 
years of age in the United States.5 The complications from biological sex and developmental 
change likely inform the conflicting results from prior literature, even when we concentrate 
on studies using longitudinal designs.
Previous studies of the Self-Medication Model differ across development and by sex. 
Hooshmand et al. followed 4,000 U.S. adolescents through high school and found those 
reporting higher depressive symptoms early had faster increases in marijuana use.17 De 
Graaf et al., with a sample of over 7,000 from a different developmental stage (late 
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adolescence to young adulthood) found that major depression predicted alcohol 
dependence.18 However, an analysis using data on a sample followed from adolescence into 
emerging adulthood found no evidence for depression predicting increases in substance use, 
measured in clusters along with sexual risk behavior.19 Previous studies of the Self-
Medication Model have also found differences by biological sex. A study with a sample of 
over 600 African American adolescents who were surveyed annually for six years starting in 
high school found depression predicted marijuana use, but only in males.9 But, Mushquash 
et al. with a sample of 200 undergraduate women found depressive symptoms predicted 
increases in heavy episodic drinking one week later.20
Though the empirical results are mixed, there is greater theoretical support for males self-
medicating depressive symptoms compared to females. First, a systematic review and 
separate meta-analysis both concluded females are more likely to use most emotion 
regulation and coping strategies compared to men.21,22 The dominant coping mechanism for 
males was impulsive reward-seeking behavior, especially using alcohol.21 Second, 
depressive symptoms can be a violation of traditional male gender norms like invulnerability 
and so males may have greater incentive to self-medicate.23 Given these factors, we 
hypothesized there would be greater support for the Self-Medication Model for males 
compared to females (Hypothesis 1).
Previous studies of the Stress Model also differ across development and by sex. Fergusson et 
al., with a sample of over 1,000 late adolescents followed into emerging adulthood, tested 
both potential directions of the association between alcohol abuse or dependence and 
depression, and found the best fitting model was leading from alcohol to depression; a recent 
review came to the same conclusion.24,25 In contrast, a study of emerging adults followed 
over a short period of time found alcohol use did not predict increases in depressive 
symtpoms.20 For marijuana, a review and two longitudinal studies of adolescents followed 
into emerging and young adulthood, respectively, found an increasing marijuana use 
trajectory, or at least weekly use, predicted later depression.26–28 However, a study of 
adolescents followed into emerging adulthood found no relationship between marijuana use 
and later depression.9 This Model is also complicated by sex. A longitudinal survey 
following over 1,000 African Americans from age six to 42 found increased alcohol or 
marijuana use in adolescence predicted psychological distress in young adulthood but only 
for males.29 By comparison, a study found substance use and sexual risk behavior in 
adolescence predicted depression in emerging adulthood, especially for females.19
Amid mixed empirical results, there are theoretical reasons to expect the Stress Model to be 
more robust among females than males. First, substance use can conflict with traditional 
female gender norms and this norm violation could predict a stronger depressive response.30 
Second, female norm violation could also predict strain in their school connectedness or 
peer and parental relationships or increased social isolation. Compared to males, females are 
more perceptive of and have stronger negative reactions to interpersonal stress and stress can 
be associated with a depressive response.12,13,31 Given these factors, we hypothesized there 
would be greater support for the Stress Model for females compared to males (Hypothesis 
2).
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The large literatures on adolescent substance use and depression share some limitations, 
which this paper aims to address. Much of the research is based on non-representative 
samples, tests only one direction, and does not test moderation by sex.9,17,28,30,32,33,6 This 
project addresses these important limitations by using data from the National Longitudinal 
Study of Adolescent to Adult Health (Add Health), a nationally representative sample, 
testing both potential directions of the association as well as moderation by sex.
Methods
Sample
Add Health has a nationally representative sample of U.S. adolescents who were in grades 
7–12 in the 1994–95 school year (Wave I). There have been four in-home interviews to date. 
The present analysis sample is restricted to respondents interviewed at Wave I, Wave III 
(ages 18 to 26), and Wave IV (ages 24 to 32), with valid sampling weights (N=12,288) and 
who had complete data on all variables of interest (N=9,816, 80%). Data from Wave II were 
not used as Wave I seniors were not followed by design. Details of the Add Health study are 
described elsewhere.34 All Add Health procedures were approved by the Institutional 
Review Board at the University of North Carolina, Chapel Hill. These analyses were deemed 
exempt.
Measures
Depressive symptoms were measured using nine items from the Center for Epidemiologic 
Studies Depression Scale (CES-D) available at Waves I, III, and IV (alpha at Wave 
III=0.80). The items ask about frequency of symptoms in the past week from rarely (0) to 
most of the time (3); the summed score for the scale ranges from 0 to 27 and the 12-month 
re-test reliability is high.35 The CES-D is not a diagnostic tool.
The substances measured included alcohol (binge drinking) and marijuana. We measured 
frequency of substance use rather than ever use to better capture levels of risk taking. The 
frequency of binge drinking, defined as consuming 5 or more drinks in a row, is assessed in 
the past 12 months with an ordinal variable ranging from 0 (never) to 6 (every day or nearly 
every day). Marijuana use frequency is assessed in the past 30 days; the measures at Waves I 
and III were continuous and assessed instances of use. At Wave IV the measure was ordinal 
and assessed days of use, mirroring the binge drinking frequency measure.34 To make the 
marijuana use frequency measures comparable across the waves, the measures at Waves I 
and III were recoded to capture days of use, assuming an instance of use was equivalent to a 
day of use, and adapted to match the ordinal measure at Wave IV.
Multiple covariates were included in the model as both depressive symptoms and substance 
use can vary across sociodemographic characteristics. The covariates included respondent’s 
self-identified race/ethnicity (Hispanic and non-Hispanic White, Black, Asian, Native 
American, and Other) and the highest educational attainment of the parents (less than high 
school, high school graduate, some college, or college graduate or higher) as a proxy for 
socioeconomic status of the parental home.5 Frequency of child maltreatment, ranging from 
never to four or more times, was included as a potential confounder as it can be significantly 
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associated with both depressive symptoms and substance use.36 Child maltreatment was 
self-reported and defined as emotional, physical, or sexual abuse before age 18 or physical 
or supervisory neglect at or before the Wave III interview. Finally, retrospective measures 
were included to control for pre-Wave I levels of the dependent variable, including a 
depression diagnosis, drinking a full alcoholic beverage, and using marijuana.
Analysis
The data set was structured by age instead of wave to capture developmental change from 
adolescence to young adulthood. Linear mixed effects models were used to estimate inter-
and intra-individual change (i.e., population average and individual-specific growth curves) 
in binge drinking frequency, marijuana use frequency, and depressive symptoms. Nine 
models were fit for each independent and dependent variable pairing. The first four models 
were used to estimate the growth curve of the dependent variable. We started with an 
unadjusted model, adding covariates, testing a random slope by age, then interacting the age 
terms with sex to test inter-individual differences in the intra-individual intercept and trend. 
The next three models test a temporal association between dual growth curves (i.e., whether 
the intercept or adolescent measure of one curve is significantly associated with the intercept 
and trend in another curve). Finally, the last two models test concurrent associations between 
dual growth curves at each age. For all eligible models, we tested moderation by sex and fit 
a random intercept by respondent ID and a random slope by age. We report the variance 
estimates for the random effects, where applicable. We also calculated the intraclass 
correlation coefficient (ICC) to get an estimate of the proportion of variance in the outcome 
that is due to variance between individuals, and report the percent change in the ICC across 
the models.
Results
Across the developmental trajectory from adolescence to young adulthood in the Add Health 
sample, the prevalence of binge drinking and marijuana use increases from adolescence to 
emerging adulthood and then decreases slightly in young adulthood. For example, from ages 
14 to 16, only 25% of respondents report any binge drinking, but this increases to 55% 
between ages 20 to 22 and then decreases to 38% between ages 32 to 34 (Table 1). For 
marijuana use, the proportion of respondents reporting any use increases from 14% at ages 
14 to 16, to 25% at ages 20 to 22, and then decreases to 17% for ages 32 to 34. Depressive 
symptoms follow an opposite pattern, starting higher in adolescence, decreasing in emerging 
adulthood and then increasing slightly in young adulthood. For example, the mean CES-D 
for ages 14 to 16 is 5.72; this decreases to 4.28 at ages 23 to 25 but then increases again to 
5.08 between ages 29 to 31.
Figure 1 is a plot of the key coefficients from the linear mixed effects models (see 
supplemental tables). The data labels show coefficient magnitude, organized from highest at 
the top of the figure to lowest at the bottom, text labels identify the coefficient.
The grey squares in Figure 1a show results from models testing the Self-Medication Model 
(i.e., the independent variable is depressive symptoms). Depressive symptoms in 
adolescence, a Wave I measure, were significantly associated with higher binge drinking 
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frequency in adolescence (b=0.03, p<0.001). The concurrent relationship across the ages 
was also significant (b=0.02, p<0.001). None of the interactions tested with the adolescent or 
time-varying (longitudinal) measure of depressive symptoms were significant. Depressive 
symptoms in adolescence were significantly associated with a steeper slope in marijuana use 
frequency with age (b=0.06, p<0.01). The concurrent relationship for depressive symptoms 
and the marijuana use frequency growth curve was also significant (b=0.03, p<0.001). The 
interactions between the longitudinal depressive symptom measure and the substance use 
frequency growth curves were not statistically significant. Self-Medication Models fit with a 
random slope for age failed to converge.
The black circles in Figure 1b show results from analyses testing the Stress Model (i.e., 
independent variable was substance use frequency). Binge drinking frequency in 
adolescence was significantly associated with a higher level of depressive symptoms in 
adolescence (b=0.67, p<0.001). The concurrent positive relationship across the ages between 
binge drinking frequency and the depressive symptom growth curve was also significant and 
moderated by sex such that the relationship is stronger for females (b=0.25, p<0.001) 
compared to males (b=0.11, p<0.01). Marijuana use frequency in adolescence was also 
significantly associated with higher adolescent depressive symptoms (b=0.59, p<0.001). The 
concurrent relationship across the ages was significant and moderated by sex, again 
indicating a stronger relationship for females (b=0.30, p<0.001) compared to males (b=0.12, 
p<0.001). All of the relevant models testing the Stress Model were fit with a random slope 
for age, allowing further heterogeneity in the growth curves.
Figure 2 shows the predicted growth curve of marijuana use frequency across age and how 
growth varies by sex and depressive symptoms (Self-Medication Model). There is an 
increase in predicted marijuana use frequency across age for those with moderate depressive 
symptoms in adolescence, especially males, but not for adolescents with no depressive 
symptoms.
Figure 3 shows the predicted growth curve of depressive symptoms across age and how 
growth varies by sex and binge drinking frequency (Stress Model). The figure displays an 
increase in predicted depressive symptoms in adolescence with an increase in binge drinking 
frequency in adolescence and a higher starting point in adolescence for females compared to 
males. Similar results were found for marijuana use frequency. The top two lines in the 
figure show variation from the mean predicted depressive growth curve from the random 
effects in the model. Specifically, they illustrate the predicted growth curve going above the 
threshold for likely depression (10 on the CES-D) given a one standard deviation increase in 
the intercept or the slope.
There is meaningful within- and between-individual variation in the growth curves. The 
ICCs decreased across the models when additional predictors were added, indicating the 
predictor and control variables explained some of the between-individual variation in the 
outcome, as expected. For example, for the Self-Medication Models, the ICCs decreased by 
30% from the unadjusted to fully-adjusted models (0.27 to 0.19) when binge drinking 
frequency was the dependent variable and by 23% (0.30 to 0.23) when marijuana use 
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frequency was the outcome. For the Stress Models, the ICCs decreased by 18% (0.34 to 
0.28).
Discussion
We used Add Health data to fit growth curve models testing both directions of the potential 
relationship between substance use and depressive symptoms from adolescence to young 
adulthood; we also tested moderation by sex. Overall and consistent with prior research, 
substance use frequency seems to increase during adolescence and start declining in 
emerging adulthood; by comparison, depressive symptoms seem to gradually increase from 
emerging to young adulthood.5,37 The ICCs decreased meaningfully across the models, 
indicating our hypothesized predictor and control variables explained considerable variation 
in growth curves between respondents. Hypothesis 1 asserted there would be greater support 
for the Self-Medication Model among males compared to females, which was not supported 
in the current analysis. Rather, the findings support the Self-Medication Model for both 
males and females as there was a significant relationship between depressive symptoms in 
adolescence and the slope of marijuana use frequency from adolescence to young adulthood. 
Hypothesis 2 asserted the Stress Model would be more applicable for females compared to 
males, and was partially supported. When we tested the association between longitudinal 
measures of both binge drinking and marijuana use frequency and the depressive symptom 
growth curve, the association was significantly moderated by sex in both cases, indicating a 
stronger positive concurrent relationship across the developmental time period for females 
compared to males. We deem this only partial support for Hypothesis 2 because the 
associations significantly moderated by sex were concurrent and not directional.
Our results indicate adolescents may self-medicate depressive symptoms with marijuana 
use. The results supporting the Self-Medication Model for marijuana use for both males and 
females are consistent with some prior studies.9,17,18 However, other longitudinal studies 
using different methods found marijuana use predicted depression and not the other way 
around, indicating methodological differences add complexity.26–28 Additionally, a similar 
prior study of over 600 African American adolescents found evidence for depression 
predicting marijuana use but only in males indicating future research should examine three-
way interactions by age, race, and sex.9
We expected to see evidence for adolescents self-medicating depressive symptoms with 
binge drinking but found no evidence to support this, consistent with some prior 
literature.17,20 Potential explanations include conceptual and methodological complications. 
For example, a study with a large sample followed from late adolescence into young 
adulthood found evidence for depression predicting alcohol, but used alcohol dependence as 
their measure, which is conceptually different than binge drinking frequency.18 Further, 
another longitudinal study found evidence for females self-medicating depressive symptoms 
with alcohol, though examined a one-week timespan compared to the years used in this and 
many prior studies, a key methodological difference.20 We especially expected to see 
evidence for self-medication with alcohol for males, as a prior review found.22 However, 
binge drinking is a normative social activity for males, especially at these ages. If only a 
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minority are self-medicating, the relationship may be hard to find.38 Future research could 
examine males self-medicating with alcohol at ages when binge drinking is less common.
From adolescence to young adulthood, persistent binge drinking or marijuana use are 
concurrently positively associated with depressive symptoms, especially for females. This 
indicates partial support for the Stress Model among females and is consistent with some 
prior literature.19,24,26–28 However, again, race/ethnicity complicate the picture. A study of 
African American and Puerto Rican women followed from adolescence into young 
adulthood found those with increasing marijuana use frequency had higher depressive 
symptoms in concordance with our results.28 But, a similar longitudinal study of African 
American children followed into adulthood found substance use in adolescence predicted 
psychological distress in adulthood only for males.29 In the prior study including Puerto 
Rican women, the women with increasing use frequency were also more likely to have a 
substance use disorder in adulthood.28 This indicates the underlying mechanism here may be 
substance dependence or abuse, signaled by a persistent pattern of substance use across 
development, rather than increased interpersonal stress from risk behavior. Indeed two 
analyses found marijuana use was only associated with later depression when it was weekly 
or daily use and another only found an association between alcohol and later depression 
when measuring alcohol dependence.24,26,27
The results of this study should be considered in the context of its limitations. First, the 
ordinal substance use measures were treated as continuous, though various robustness 
checks indicate the results are stable to variations in the measures (results not shown). 
Second, though linear mixed effects models remove potential bias from time-invariant 
unobserved characteristics, the results could still be biased by time-varying unobserved 
characteristics. Third, the Add Health data allow the developmental time period from 
adolescence into young adulthood to be studied; however, with only three waves of data (i.e., 
developmental periods) with the entire sample, it is more difficult to find variation in the 
growth curves. Though the adolescent data was collected two decades ago, the prevalence of 
our key variables have not changed neither has the likely relationships between them.39 
Fourth, complete case analysis increased the proportion missing but is recommended for 
analysis of Add Health data; multiple imputation was not a viable option for the items with 
the highest proportion missing.40
This paper addressed several limitations in past literature by using data from a nationally 
representative sample followed from adolescence into young adulthood and testing both 
potential directions of the association between substance use and depressive symptoms, as 
well as possible moderation by sex. The results indicate youth may self-medicate their 
depressive symptoms with marijuana use and that both marijuana use and binge drinking are 
concurrently associated with depressive symptoms, especially among females. So, both 
Models were supported and there was modest evidence suggesting the Stress Model is a 
better fit for females than males. These results inform efforts to screen adolescents for 
depression or substance use. For example, youth screening positive for depression or an 
increase in depressive symptoms should also be screened for marijuana use, and youth, 
especially females, screening positive for persistent binge drinking or marijuana should be 
targeted for depression prevention programs or at least flagged as at risk for depressive 
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symptoms. Future research should examine moderation in these pathways by both sex and 
race/ethnicity as well as variation in results across different longitudinal methods and 
conceptualizations of substance use frequency and/or abuse/dependence.
Supplementary Material
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Implications and Contribution
Adolescents may medicate depressive symptoms with marijuana use. Persistent binge 
drinking or marijuana use from adolescence to young adulthood associated with higher 
concurrent depressive symptoms, associations were stronger for females.
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Figure 1. 
Key coefficients from the linear mixed effects models
aBinge drinking frequency (BD), marijuana use frequency (MJ), Wave I (WI), dependent 
variable noted with parentheses in Figure 1a
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Figure 2. 
Relationship between adolescent depressive symptoms and marijuana use frequency growth 
curve (Self-Medication Model)a
aAdolescent (adol), dep (depressive)
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Figure 3. 
Relationship between adolescent binge drinking frequency and depressive symptoms growth 
curve (Stress Model)a
aAdolescence (adol.)
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